Literature DB >> 4367232

Evaluation of a new mucolytic drug.

S N Steen, I Ziment, D Freeman, J S Thomas.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4367232     DOI: 10.1002/cpt1974161part158

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

1.  Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Authors:  P H Weller; D Ingram; M A Preece; D J Matthew
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

Review 2.  Therapeutic approaches to mucus hypersecretion.

Authors:  Atsushi Yuta; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.